Abstract
Patients with asbestos related malignant mesothelioma excrete high levels of modified nucleosides in their urine. The purpose of the present report was to explore further the usefulness of measuring these breakdown products of transfer RNA (tRNA) in male asbestos insulation workers who are at high neoplastic risk but without clinical signs of malignancy. Modified nucleoside levels (psi, m'A, m'I, m2G, and ac4C) were used as discriminator variables in a computer generated discriminant function in which 96% of the controls and 95% of the insulation workers were correctly classified. It was also found, using a similar multiple regression model, that 10 of 13 were correctly classified as having normal chest radiographs and 27 of 30 asbestos exposed subjects as exhibiting alterations in either the parenchyma, pleura, or both. The results suggest that measuring modified nucleosides levels in the urine of asbestos exposed workers, and perhaps others exposed to carcinogenic agents, has the potential for identifying, through multivariate statistical techniques, individuals who are at high neoplastic risk.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Borek E., Baliga B. S., Gehrke C. W., Kuo C. W., Belman S., Troll W., Waalkes T. P. High turnover rate of transfer RNA in tumor tissue. Cancer Res. 1977 Sep;37(9):3362–3366. [PubMed] [Google Scholar]
- Fischbein A., Sharma O. K., Selikoff I. J., Borek E. Urinary excretion of modified nucleosides in patients with malignant mesothelioma. Cancer Res. 1983 Jun;43(6):2971–2974. [PubMed] [Google Scholar]
- Fischbein A., Sharma O. K., Solomon S., Buschman F., Apell G., Kohn M., Selikoff I. J., Bekesi J. G., Borek E. Transfer RNA breakdown products in the urine of asbestos workers. Cancer Detect Prev. 1984;7(4):247–252. [PubMed] [Google Scholar]
- Gehrke C. W., Kuo K. C., Davis G. E., Suits R. D., Waalkes T. P., Borek E. Quantitative high-performance liquid chromatography of nucleosides in biological materials. J Chromatogr. 1978 Mar 21;150(2):455–476. doi: 10.1016/s0021-9673(00)88205-9. [DOI] [PubMed] [Google Scholar]
- Gehrke C. W., Kuo K. C., Waalkes T. P., Borek E. Patterns of urinary excretion of modified nucleosides. Cancer Res. 1979 Apr;39(4):1150–1153. [PubMed] [Google Scholar]
- Rasmuson T., Björk G. R., Damber L., Holm S. E., Jacobsson L., Jeppsson A., Littbrand B., Stigbrand T., Westman G. Evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphatase, and modified nucleosides as biological markers in malignant lymphomas. Recent Results Cancer Res. 1983;84:331–343. doi: 10.1007/978-3-642-81947-6_25. [DOI] [PubMed] [Google Scholar]
- Sharma O. K., Waalkes T. P., Gehrke C. W., Borek E. Applications of urinary nucleosides in cancer diagnosis and cancer management. Cancer Detect Prev. 1983;6(1-2):77–85. [PubMed] [Google Scholar]